Tomoaki Kato Selected Research

Hepatocellular Carcinoma (Hepatoma)

1/2022	Stable liver graft post anti-PD1 therapy as a bridge to transplantation in an adolescent with hepatocellular carcinoma.
1/2017	Recurrence After Liver Transplantation for Hepatocellular Carcinoma: A New MORAL to the Story.
11/2015	Hepatocellular Carcinoma in Noncirrhotic Liver with Glycogenotic Foci: Basic Science Meets Genomic Medicine.
3/2015	Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinoma.
1/2015	Serum adiponectin is associated with worsened overall survival in a prospective cohort of hepatocellular carcinoma patients.
12/2014	Standing the test of time: outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment.
9/2012	Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation.
5/2004	Competing risks analysis of predictors of delisting owing to tumor progression in liver transplant candidates with hepatocellular carcinoma.
9/2003	Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted livers.
11/2002	Comparison of hepatic resection and hepatic transplantation in the treatment of hepatocellular carcinoma among cirrhotic patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomoaki Kato Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 01/2002
10	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 11/2002
10	Infections 12/2020 - 03/2002
5	Intestinal Failure 06/2005 - 02/2002
3	Wounds and Injuries (Trauma) 06/2015 - 02/2004
3	Short Bowel Syndrome 01/2007 - 03/2006
3	Thrombosis (Thrombus) 02/2005 - 11/2002
2	Liver Diseases (Liver Disease) 01/2021 - 04/2013
2	Diarrhea 12/2020 - 03/2015
2	Hepatitis 12/2020 - 04/2003
2	Acute Liver Failure (Fulminant Hepatic Failure) 07/2016 - 04/2016
2	Diabetes Mellitus 01/2015 - 10/2007
2	Death (Near-Death Experience) 12/2014 - 11/2012
2	Ischemia 04/2013 - 07/2004
2	Bacteremia 11/2007 - 02/2007
2	Fibrosis (Cirrhosis) 10/2007 - 11/2002
2	Hepatitis B 03/2007 - 04/2003
2	Liver Failure 02/2007 - 03/2002
2	Respiratory Insufficiency (Respiratory Failure) 04/2005 - 03/2002
1	Sarcoma (Soft Tissue Sarcoma) 08/2022
1	Carcinoma (Carcinomatosis) 10/2021
1	Fever (Fevers) 12/2020
1	Abdominal Neoplasms (Abdominal Neoplasm) 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2018
1	Hemorrhage 03/2016
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2016
1	Homozygous Familial Hypercholesterolemia 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Hernia (Hernias) 06/2015
1	Hand-Foot Syndrome 03/2015
1	Hypertension (High Blood Pressure) 03/2015
1	Leukopenia 03/2015
1	Hemangiosarcoma (Angiosarcoma) 10/2014
1	Disease Resistance 09/2011
1	Brain Death (Brain Dead) 08/2011
1	Reperfusion Injury 08/2011
1	Primary Graft Dysfunction 08/2011
1	Hypersplenism (Anemia, Splenic) 02/2010
1	Hepatitis C 12/2009
1	Budd-Chiari Syndrome (Budd Chiari Syndrome) 05/2009
1	Anuria 03/2009
1	Wound Infection (Wound Infections) 10/2007
1	Hirschsprung Disease (Hirschsprung's Disease) 06/2007
1	Gastroschisis 11/2006
1	Ulcer 03/2006

Drug/Important Bio-Agent (IBA)

3	SteroidsIBA 10/2007 - 12/2002
3	Immunoglobulins (Immunoglobulin)IBA 03/2007 - 01/2002
2	Biomarkers (Surrogate Marker)IBA 03/2015 - 08/2011
2	CitrullineIBA 09/2008 - 11/2007
2	hepatitis B hyperimmune globulinIBA 03/2007 - 04/2003
2	Lamivudine (Epivir)FDA Link 03/2007 - 04/2003
2	AntigensIBA 04/2003 - 01/2003
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 12/2020
1	EnzymesIBA 12/2020
1	gamma-Globulins (gamma-Globulin)IBA 12/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2020
1	Hemostatics (Antihemorrhagics)IBA 03/2016
1	SurgicelIBA 03/2016
1	purified rayonIBA 03/2016
1	Dihydrotachysterol (AT 10)IBA 03/2016
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 03/2016
1	TachoSilIBA 03/2016
1	oxidized low density lipoproteinIBA 01/2016
1	Blood Glucose (Blood Sugar)IBA 01/2016
1	LipidsIBA 01/2016
1	Lipoproteins (Lipoprotein)IBA 01/2016
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2016
1	LDL CholesterolIBA 01/2016
1	LDL Receptors (LDL Receptor)IBA 01/2016
1	TransferasesIBA 03/2015
1	Sorafenib (BAY 43-9006)FDA Link 03/2015
1	AdiponectinIBA 01/2015
1	Adiponectin ReceptorsIBA 01/2015
1	AdipokinesIBA 01/2015
1	dicarboxydine (DCD)IBA 12/2014
1	DefensinsIBA 09/2011
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2007
1	antineoplaston A10 (A 10)IBA 06/2007
1	lipoarabinomannan (LAM)IBA 03/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2007
1	serum P-component (CIt)IBA 01/2006

Therapy/Procedure

27	Liver Transplantation 01/2021 - 01/2002
20	Transplantation 01/2022 - 02/2002
8	Therapeutics 01/2022 - 05/2003
5	Autologous Transplantation 11/2020 - 07/2012
2	Hepatectomy 06/2015 - 04/2013
2	Surgical Splenorenal Shunt (Splenorenal Shunt) 02/2010 - 12/2005
2	Total Parenteral Nutrition 03/2006 - 03/2002
1	Radiotherapy 08/2022
1	Immunotherapy 01/2022
1	Precision Medicine 10/2021
1	Pancreaticoduodenectomy 12/2015
1	Genomic Medicine 11/2015
1	Kidney Transplantation 08/2011
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 05/2009
1	Renal Dialysis (Hemodialysis) 03/2009
1	Central Venous Catheters 02/2007
1	Parenteral Nutrition 02/2007
1	Catheters 02/2007